Physician profile
Mallory Harlin
NPI 1689019226
$2,362.60
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $385 · 2021: $338 · 2022: $347.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $822.49 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $247.50 | 2019-2021 | |
| Lilly USA, LLC | $183.65 | 2019-2020 | |
| Glaxosmithkline, LLC. | $180.76 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $149.41 | 2019-2020 | |
| Amarin Pharma, INC. | $95.91 | 2019-2020 | |
| Abbvie INC. | $94.93 | 2019-2022 | |
| Amgen INC. | $75.51 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.02 | 2019-2020 | |
| Pfizer INC. | $71.29 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.84 | 2019-2021 | |
| Allergan, INC. | $60.40 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $46.88 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $39.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.55 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $32.36 | 2022 | |
| Genentech USA, INC. | $27.46 | 2019-2022 | |
| Shire North American Group INC | $21.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.24 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Harlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.